AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 LannettVerrica PharmaceuticalsTherapeuticsMDCalithera BiosciencesCytomX Therapeutics
SymbolNYSE:LCINASDAQ:VRCANASDAQ:TXMDNASDAQ:CALANASDAQ:CTMX
Price Information
Current Price$7.65$11.48$1.13$5.81$8.86
52 Week RangeHoldBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.61.51.51.61.6
Analysis Score3.03.53.43.54.4
Community Score2.72.32.62.82.8
Dividend Score0.00.00.00.00.0
Ownership Score1.01.01.01.01.0
Earnings & Valuation Score1.30.60.60.60.0
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$14.00$22.00$8.67$8.50$14.00
% Upside from Price Target83.01% upside91.64% upside666.96% upside46.30% upside58.01% upside
Trade Information
Market Cap$307.87 million$357.79 million$309.72 million$417.71 million$415.15 million
Beta1.932.462.242.360.78
Average Volume732,64461,8864,571,952741,062545,937
Sales & Book Value
Annual Revenue$655.41 millionN/A$49.65 million$22.25 million$57.49 million
Price / Sales0.47N/A6.1818.397.08
Cashflow$3.75 per shareN/AN/AN/AN/A
Price / Cash2.04N/AN/AN/AN/A
Book Value$7.70 per share$2.19 per share($0.17) per share$1.81 per share$1.52 per share
Price / Book0.99N/A-6.653.215.83
Profitability
Net Income$-272,110,000.00$-28,210,000.00$-176,150,000.00$-89,860,000.00$-102,240,000.00
EPS$2.35($1.13)($0.68)($1.90)($2.26)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E Ratio6.48N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-5.77%N/A-333.88%N/A-97.83%
Return on Equity (ROE)14.54%-45.24%-1,170.63%-68.38%-99.72%
Return on Assets (ROA)3.98%-38.17%-71.17%-57.43%-19.52%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.96%0.61%22.15%0.05%0.35%
Current Ratio1.97%27.45%3.44%8.75%3.77%
Quick Ratio1.37%27.45%3.20%8.75%3.77%
Ownership Information
Institutional Ownership Percentage91.31%34.45%67.09%71.34%78.59%
Insider Ownership Percentage12.86%40.20%13.76%17.20%6.30%
Miscellaneous
Employees1,0201634890137
Shares Outstanding40.35 million25.81 million271.68 million70.44 million45.92 million
Next Earnings Date8/25/2020 (Estimated)8/5/2020 (Estimated)8/4/2020 (Estimated)8/13/2020 (Estimated)8/5/2020 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.